CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
TRAIL – A New Mediator in Fatty Liver Disease
DOI 10.1055/s-0035-1555355
Bibliografische Angaben
Nachweis in CareLit
Autor:innenB Mundt, M Waltemathe, MP Manns, S Kubicka
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: TRAIL, a member of the TNF-ligand-family, is capable to induce apoptosis in cancer and is involved the eradication of virally infected cells. Methods/Results: We investigated liver tissues of patients with chronic HCV-infection and observed an upregulation of TRAIL expression in western blotting accompanied by fatty liver disease (FLD) as demonstrated by oil-red staining. To further evaluate the role of…
Zitieren
Zitierempfehlung
B Mundt, M Waltemathe, MP Manns, S Kubicka (2015) TRAIL – A New Mediator in Fatty Liver Disease. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-0035-1555355
Mit CareLit weiterarbeiten